Latest Conference Articles

The OncLive® Conference page includes a listing of all conferences covered by OncLive®, including the ASCO, ESMO, SITC, EHA, ASH, and SABCS annual meetings, as well as the Chemotherapy Foundation Symposium and Miami Breast Cancer Conference, among many others. Conference coverage incorporates articles and interviews in written and video format.

29th Annual Miami Breast Cancer Conference Slideshow

March 15th 2012, 6:00am

PER® Miami Breast Cancer Conference

Pictures from the Annual Miami Breast Cancer Conference, at the Fontainebleau Miami Beach hotel, in Florida.

Four Key Areas Are Focus of ASCO/SABCS Highlights

March 14th 2012, 6:27am

PER® Miami Breast Cancer Conference

Debu Tripathy, MD, culled the highlights from abstracts presented in 2011 at the ASCO annual meeting in Chicago, Illinois, and at the CCTR-AARC SABCS in Texas.

29th Annual Miami Breast Cancer Conference Opens

March 14th 2012, 5:55am

PER® Miami Breast Cancer Conference

The impact of molecular and genomic advancements on the treatment of patients with breast cancer will be among the prime topics of discussion.

Miami Breast Cancer Conference Founder Keeps Focus on Future

March 12th 2012, 1:34pm

PER® Miami Breast Cancer Conference

As the Miami Breast Cancer Conference enters its 29th year, Osman continues to organize the gathering and pack the 4-day meeting with faculty speakers.

Dr. Steensma Discusses Iron Chelation Therapy for MDS

February 27th 2012, 4:11pm

Hematologic Malignancies Congress

Dr. David Steensma, from Dana-Farber Cancer Institute, Discusses Iron Chelation Therapy for MDS

Managing Chronic Myeloid Leukemia Treatment

February 27th 2012, 12:50pm

Hematologic Malignancies Congress

Certain characteristics of patients with CML can affect therapeutic outcomes.

New Model Helps Guide Treatment Options in CLL

February 27th 2012, 12:17pm

Hematologic Malignancies Congress

A number of prognostic factors can help identify those at a high risk for CLL progression who may benefit from early intervention.

Dr. Erba Describes Proper Diagnostic Testing of CML

February 27th 2012, 10:34am

Hematologic Malignancies Congress

Dr. Harry Erba, from the University of Michigan Health System, Describes Proper Diagnostic Testing of CML

2012 ONS Congress Coverage Coming Soon

February 25th 2012, 3:22pm

Oncology Nursing Society Congress

Meeting coverage from the 2012 Oncology Nursing Society Congress held at the New Orleans Ernest N. Morial Convention Center, from May 3-6, 2012.

Dr. Dunleavy Discusses 3 Molecular Subtypes of DLBCL

February 24th 2012, 4:28pm

Hematologic Malignancies Congress

Dr. Kieron Dunleavy from the National Cancer Institute Discusses 3 Molecular Subtypes of DLBCL

Current Trends in the Treatment of Newly Diagnosed Myeloma

February 24th 2012, 2:34pm

Hematologic Malignancies Congress

A number of studies suggest that there is a right and wrong way to proceed with initial therapy and transplant eligibility for patients with multiple myeloma.

New Directions in Relapsed/Refractory Diffuse Large B-cell Lymphoma

February 24th 2012, 9:40am

Hematologic Malignancies Congress

Research has shown that DLBCL is heterogeneous, suggesting that patients with varying subtypes should receive different courses of treatment.

Dr. Ansell on Waldenstrom Macroglobulinemia Types

February 24th 2012, 9:39am

Hematologic Malignancies Congress

Dr. Stephen Ansell from the Mayo Clinic Describes Waldenström Macroglobulinemia

Noted Researcher Sees ERT as Remarkable Beginning

January 26th 2012, 3:23pm

Updates From the ICHG/ASHG 61st Annual Meeting

The treatment of Gaucher disease is poised to enter a new era as a result of advances in the understanding of the cellular pathways at work in the disorder.

Same Mission, New Role for Genzyme Executive: Head of Rare Diseases Committed to Patients

January 21st 2012, 3:45pm

Updates From the ICHG/ASHG 61st Annual Meeting

Rogerio Vivaldi, MD, has vivid memories of the first patient with Gaucher disease ever treated in Brazil with enzyme replacement therapy.

Lysosomal Storage Disorders: Marking Milestones and Moving Forward

January 18th 2012, 3:03pm

Updates From the ICHG/ASHG 61st Annual Meeting

The mood of the ICHG/ASHG 2011 congress often seemed buoyant as researchers discussed the doors that technology is helping to open.

Dr. Grabowski Explains the Effects of Enzyme Therapy

January 14th 2012, 4:09pm

Updates From the ICHG/ASHG 61st Annual Meeting

Dr. Gregory Grabowski, from the University Cincinnati, Explains the Effects of Enzyme Therapy

Dr. Mistry Discusses His Experience With Gaucher Disease

January 11th 2012, 3:10pm

Updates From the ICHG/ASHG 61st Annual Meeting

Pramod K. Mistry, MD, PhD, from Yale University, discusses Gaucher disease

Dr. Mato on the Benefits of the JTCC Retrospective Trial

December 13th 2011, 4:27pm

ASH Annual Meeting and Exposition

Dr. Anthony Mato From the John Theurer Cancer Center Discusses the Benefits of the JTCC Retrospective Trial

Photos From the 2011 ASH Annual Meeting and Exposition

December 13th 2011, 4:06pm

ASH Annual Meeting and Exposition

A collection of photos from the ASH 53rd annual meeting at the San Diego Convention Center in San Diego, CA, from December 10-13, 2011.

x